Files and links (1)
Open Access CC BY V4.0
Journal article
Cardiovascular outcomes for Australian women with rheumatic heart disease during pregnancy: A retrospective linked data analysis, 2002-2017
Acta obstetricia et gynecologica Scandinavica, Vol.105(8), pp.1531-1541
2026
PMID: 42210517
Abstract
Introduction
Rheumatic heart disease (RHD) is the acquired autoimmune heart valve damage resulting from untreated infection with the Streptococcus pyogenes bacterium, which affects people experiencing socioeconomic disadvantage globally. This study measured RHD-associated major adverse cardiovascular events (MACE) and the increased risk associated with pregnancy among women diagnosed with RHD.
Material and Methods
Population-level analysis of all births to women with RHD in four Australian jurisdictions was conducted, which covered 71% of the total population and 88% of the Aboriginal and Torres Strait Islander population (a group who experience some of the highest RHD rates reported globally). A retrospective cohort study using linked RHD register and midwives, hospital, and death data collections was designed. Females with at least one birth record aged 12–44 years, whose first RHD diagnosis occurred prior to 20 weeks' gestation and age < 35 years, were identified during 2002–2017. Survival methods (incorporating mixed effects and time-varying covariates) estimated proportions and hazard ratios. Probability of hospitalization for new RHD-associated MACE was measured for pulmonary hypertension secondary to left heart disease, heart failure, valvular surgery, stroke, infective endocarditis, atrial fibrillation, acute pulmonary edema, cardiomyopathy, and/or death.
Results
We identified 558 pregnancies in women with uncomplicated RHD (345 women) and 88 pregnancies in women with complicated RHD (60 women). During pregnancy, 4.5% of women with uncomplicated RHD and 31.8% of women with complicated RHD experienced new RHD-associated MACE. Risk of RHD-associated MACE was three- to six-fold higher during periods of pregnancy (compared with non-pregnancy) and did not differ by RHD stage.
Conclusions
After 20 weeks of gestation, women with RHD experienced RHD-associated MACE outcomes at frequencies that were contingent upon RHD stage at 20 weeks of gestation. Awareness of RHD status before 20 weeks of gestation, especially in regions where RHD is endemic, is critical for ensuring women's cardiovascular health in pregnancy and beyond.
Details
- Title
- Cardiovascular outcomes for Australian women with rheumatic heart disease during pregnancy: A retrospective linked data analysis, 2002-2017
- Authors/Creators
- Ingrid Stacey - The University of Western AustraliaMohammed Junaid - The University of Western AustraliaHolger W Unger - Royal Darwin HospitalGeraldine Vaughan - Central Queensland UniversityYe'elah Berman - King Edward Memorial HospitalVicki Wade - Charles Darwin UniversityLee Nedkoff - The University of Western AustraliaJames Marangou - Charles Darwin UniversityJudith M Katzenellenbogen - Perth Children's Hospital
- Publication Details
- Acta obstetricia et gynecologica Scandinavica, Vol.105(8), pp.1531-1541
- Publisher
- John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
- Number of pages
- 11
- Grant note
- 110335 / National Heart Foundation of Australia 1146525 / National Health and Medical Research Council 108106 / National Heart Foundation of Australia
- Identifiers
- 991005886393807891
- Copyright
- © 2026 The Author(s)
- Murdoch Affiliation
- Ngangk Yira Institute for Change
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: SDGs in the Output
Metrics
1 Record Views